High-Risk, High-Reward Investors Should Love Milestone Scientific

  • The company has a drug delivery technology platform with multiple uses.
  • One is already commercialized for dental practices and produces cash flow for developing and commercializing other applications.
  • Management is concentrating on the CompuFlo Epidural, and the device looks on the edge of a commercial breakthrough.
  • The economic case for hospitals and insurance companies is compelling.

Source: High-Risk, High-Reward Investors Should Love Milestone Scientific – Milestone Scientific Inc. (NYSEMKT:MLSS) | Seeking Alpha